Role of CFTR gene mutation variants according to the CFTR-France database in idiopathic pancreatitis: does the type matter?
Abstract
Background
Pancreatitis can be associated with several CFTR-gene mutations. The CFTR-France database classifies variants as disease-causing (DC), variants of unknown significance (VUS), and non-disease-causing (NDC) according to clinical consequences. This study aims to investigate clinical features and outcomes in patients with idiopathic pancreatitis carrying different CFTR mutation types, according to the CFTR-France database.
Methods
In this retrospective study, all consecutive patients with idiopathic pancreatitis observed over an 8-year period at the University of Verona Gastroenterology-Unit and investigated for CFTR-gene mutations were included. Patients were divided into wild-type (WT-group) and CFTR-gene mutations carriers (CFTR-group). CFTR group was further classified according to number (single mutation-CFTR1 Vs. compound mutations-CFTR2) and mutation type (DC, VUS, and NDC). Epidemiological, clinical, instrumental, and functional characteristics at clinical onset and during follow-up were evaluated for progression to chronic pancreatitis (CP), onset of pancreatic calcifications, and development of exocrine and endocrine pancreatic insufficiency.
Results
We included 99 patients (65 males, age 29 ± 13 years) in CFTR-group, and 223 patients (134 males, age 38.2 ± 15.7 years) in WT-group. The clinical course of WT patients was characterized by earlier progression to chronic pancreatitis, onset of calcifications, and exocrine pancreatic insufficiency compared to CFTR-group, although this was probably influenced by the higher prevalence of risk factors, in particular smoking. No significant differences were observed according to number and type of CFTR-gene mutations.
Conclusions
Idiopathic pancreatitis patients carrying CFTR-gene mutation(s) have different clinical outcome compared to WT. Number and type of mutations do not seem to modify the clinical outcome of patients.